Dane Andreeff - 30 Nov 2023 Form 4 Insider Report for HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)

Role: President and CEO, Director, 10%+ Owner
Signature: /s/ Dane Andreeff
Issuer symbol: HSDT
Transactions as of: 30 Nov 2023
Net transactions value: +$25,675
Form type: 4
Filing time: 04 Dec 2023, 08:30:12 UTC
Previous filing: 30 Aug 2023
Next filing: 15 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HSDT	Common Stock	Purchase	$7,205	+1,131	+9.9%	$6.37	12,551	30 Nov 2023	See footnote	F1
transaction	HSDT	Common Stock	Purchase	$1,452	+228	+9.6%	$6.37	2,603	30 Nov 2023	See footnote	F2
transaction	HSDT	Common Stock	Purchase	$4,083	+641	+6.4%	$6.37	10,633	30 Nov 2023	See footnote	F3
transaction	HSDT	Common Stock	Purchase	$7,312	+1,134	+9%	$6.45	13,685	01 Dec 2023	See footnote	F1
transaction	HSDT	Common Stock	Purchase	$1,477	+229	+8.8%	$6.45	2,832	01 Dec 2023	See footnote	F2
transaction	HSDT	Common Stock	Purchase	$4,146	+643	+6%	$6.45	11,276	01 Dec 2023	See footnote	F3
holding	HSDT	Common Stock						599	30 Nov 2023	See footnote	F4
holding	HSDT	Common Stock						30	30 Nov 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F2	The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I and as such may be deemed to beneficially own the securities owned by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F3	The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I and as such may be deemed to beneficially own the securities owned by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F4	The shares are held by Maple Leaf Offshore Ltd. ("MLO"). The reporting person is the president of the managing member of Andreeff Equity Advisors, L.L.C., the investment manager of MLO and as such may be deemed to beneficially own the securities owned by MLO. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.